The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis
Abstract
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalence of primary aldosteronism is necessary. Reported prevalences of primary aldosteronism are highly variable, possibly due to study heterogeneity. OBJECTIVE: Our objective was to identify and explain heterogeneity in studies that aimed to establish the prevalence of primary aldosteronism in hypertensive patients. DATA SOURCES: PubMed, EMBASE, Web of Science, Cochrane Library, and reference lists from January 1, 1990, to January 31, 2015, were used as data sources. STUDY SELECTION: Description of an adult hypertensive patient population with confirmed diagnosis of primary aldosteronism was included in this study. DATA EXTRACTION: Dual extraction and quality assessment were the forms of data extraction. DATA SYNTHESIS: Thirty-nine studies provided data on 42 510 patients (nine studies, 5896 patients from primary care). Prevalence estimates varied from 3.2% to 12.7% in primary care and from 1% to 29.8% in referral centers. Heterogeneity was too high to establish point estimates (I(2) = 57.6% in primary care; 97.1% in referral centers). Meta-regression analysis showed higher prevalences in studies 1) published after 2000, 2) from Australia, 3) aimed at assessing prevalence of secondary hypertension, 4) that were retrospective, 5) that selected consecutive patients, and 6) not using a screening test. All studies had minor or major flaws. CONCLUSIONS: This study demonstrates that it is pointless to claim low or high prevalence of primary aldosteronism based on published reports. Because of the significant impact of a diagnosis of primary aldosteronism on health care resources and the necessary facilities, our findings urge for a prevalence study whose design takes into account the factors identified in the meta-regression analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Pedrosa, R. P., Drager, L. F., Gonzaga, C. C., Sousa, M. G., de Paula, L. K. G., Amaro, A. C. S., Amodeo, C., Bortolotto, L. A., Krieger, E. M., Bradley, T. D., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179788 · Cited by 668
Recent developments in meta‐analysis
Sutton, A. J., & Higgins, J. P. T. (2008) · Statistics in Medicine · doi:10.1002/sim.2934 · Cited by 590
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562
Douma, S., Petidis, K., Doumas, M., Papaefthimiou, P., Triantafyllou, A., Kartali, N., Papadopoulos, N., Vogiatzis, K., & Zamboulis, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60834-x · Cited by 560
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 496
Primary Aldosteronism and Hypertensive Disease
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., & Fardella, C. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000079505.25750.11 · Cited by 488
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 392
Catena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P., & Sechi, L. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095448 · Cited by 358
Rossi, G. P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M. V., Bisogni, V., Mantero, F., & Pessina, A. C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01316 · Cited by 356
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Sawka, A. M., Young, W. F., Thompson, G. B., Grant, C. S., Farley, D. R., Leibson, C., & van Heerden, J. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00010 · Cited by 347
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
Loh, K.-C., Koay, E. S., Khaw, M.-C., Emmanuel, S. C., & Young, W. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6752 · Cited by 345
Hannemann, A., & Wallaschofski, H. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295438 · Cited by 340
Stowasser, M., Gordon, R. D., Gunasekera, T. G., Cowley, D. C., Ward, G., Archibald, C., & Smithers, B. M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00025 · Cited by 280
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P., Dow, E., Brennan, G., Jung, R., & MacDonald, T. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 269
Low-renin status in therapy-resistant hypertension: a clue to efficient treatment
Eide, I. K., Torjesen, P. A., Drolsum, A., Babovic, A., & Lilledahl, N. P. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00026 · Cited by 265
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., & Harding, S. M. (2004) · Chest · doi:10.1378/chest.125.1.112 · Cited by 260
Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237
Schwartz, G. L., & Turner, S. T. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041780 · Cited by 221
Gordon, R. D., Ziesak, M. D., Tunny, T. J., Stowasser, M., & Klemm, S. A. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01687.x · Cited by 191
Factors Influencing Outcome of Surgery for Primary Aldosteronism
Celen, O. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430180072015 · Cited by 179
Seifarth, C., Trenkel, S., Schobel, H., Hahn, E. G., & Hensen, J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01613.x · Cited by 176
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
Reincke, M., Rump, L. C., Quinkler, M., Hahner, S., Diederich, S., Lorenz, R., Seufert, J., Schirpenbach, C., Beuschlein, F., Bidlingmaier, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1851 · Cited by 175
Rossi, E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02969-2 · Cited by 164
Cardiovascular complications in patients with primary aldosteronism
Nishimura, M., Uzu, T., Fujii, T., Kuroda, S., Nakamura, S., Inenaga, T., & Kimura, G. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70298-2 · Cited by 160
Shamliyan, T., Kane, R. L., Ansari, M., Raman, G., Berkman, N. D., Grant, M. D., Janes, G. R., Maglione, M., Moher, D., Nasser, M., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.08.006 · Cited by 150
Is There an Unrecognized Epidemic of Primary Aldosteronism? (Pro)
Calhoun, D. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.086116 · Cited by 149
NISHIZAKA, M., PRATTUBUNAMA, M., ZAMAN, M., COFIELD, S., & CALHOUN, D. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.01.002 · Cited by 146
Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
Sywak, M. S., & Pasieka, J. L. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02261.x · Cited by 140
Fogari, R., Preti, P. S., Zoppi, A., Rinaldi, A., Fogari, E., & Mugellini, A. (2007) · Hypertension Research · doi:10.1291/hypres.30.111 · Cited by 134
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Muiesan, M. L., Salvetti, M., Paini, A., Agabiti-Rosei, C., Monteduro, C., Galbassini, G., Belotti, E., Aggiusti, C., Rizzoni, D., Castellano, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114140 · Cited by 127
Di Murro, A., Petramala, L., Cotesta, D., Zinnamosca, L., Crescenzi, E., Marinelli, C., Saponara, M., & Letizia, C. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310366581 · Cited by 125
Plouin, P., Amar, L., & Châtellier, G. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh112 · Cited by 124
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia
Williams, J. S., Williams, G. H., Raji, A., Jeunemaı̂tre, X., Brown, N. J., Hopkins, P. N., & Conlin, P. R. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001948 · Cited by 115
Relations between cardiac and vascular structure in patients with primary and secondary hypertension
Rizzoni, D., Muiesan, M. L., Porteri, E., Salvetti, M., Castellano, M., Bettoni, G., Tiberio, G. A. M., Giulini, S. M., Monteduro, C., Garavelli, G., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00322-2 · Cited by 106
Holaj, R., Zelinka, T., Wichterle, D., Petrák, O., Štrauch, B., & Widimsky, J., Jr. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281268532 · Cited by 99
Sang, X., Jiang, Y., Wang, W., Yan, L., Zhao, J., Peng, Y., Gu, W., Chen, G., Liu, W., & Ning, G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328360ddf6 · Cited by 90
Screening for primary aldosteronism with a logistic multivariate discriminant analysis*
Rossi, G. P., Rossi, E., Pavan, E., Rosati, N., Zecchel, R., Semplicini, A., Perazzoli, F., & Pessina, A. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00608.x · Cited by 83
Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism
Jansen, P. M., van den Born, B. H., Frenkel, W. J., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Smulders, Y. M., Woittiez, A. J. J., Wijbenga, J. A. M., Zietse, R., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283656b54 · Cited by 78
Self-citationEffect of Age on Response of Secondary Hypertension to Specific Treatment
Streeten, D. H. P., Anderson, G. H., & Wagner, S. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.5.360 · Cited by 76
The challenge of more robust and reproducible methodology in screening for primary aldosteronism
Gordon, R. D. (2004) · Journal of Hypertension · doi:10.1097/00004872-200402000-00006 · Cited by 69
Trenkel, S., Seifarth, C., Schobel, H.-P., Hahn, E. G., & Hensen, J. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-23491 · Cited by 65
Primary hyperaldosteronism: A missed diagnosis in ‘essential hypertensives’?
Brown, M. A., Cramp, H., Zammit, V. C., & Whitworth, J. A. (1996) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1996.tb00600.x · Cited by 57
Prevalence of Adrenal and Extra-adrenal Conn Syndrome in Hypertensive Patients
Abdelhamid, S., Müller-Lobeck, H., Pahl, S., Remberger, K., Bönhof, J. A., Walb, D., & Röckel, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100086010 · Cited by 56
Aldosterone to Renin Ratio – A Reliable Screening Tool for Primary Aldosteronism?
Tomaschitz, A., & Pilz, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1248326 · Cited by 52
MARTELL, N., RODRIGUEZ-CERRILLO, M., GROBBEE, D. E., LÓPEZ-EADY, M. D., FERNÁNDEZ-PINILLA, C., AVILA, M., FERNANDEZ-CRUZ, A., & LUQUE, M. (2003) · Blood Pressure · doi:10.1080/08037050310009950 · Cited by 49
Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study.
Jansen, P. M., Boomsma, F., & van den Meiracker, A. H. (2008) · PubMed · Cited by 46
Westerdahl, C., Bergenfelz, A. O. J., Isaksson, A., Nerbrand, C., & Valdemarsson, S. V. (2011) · Europe PMC (PubMed Central) · doi:10.3109/02813432.2011.554015 · Cited by 43
Treatment of Primary Aldosteronism and Organ Protection
Catena, C., Colussi, G., & Sechi, L. A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/597247 · Cited by 36
Yin, G., Zhang, S., Yan, L., Wu, M., Xu, M., Li, F., & Cheng, H. (2012) · Endocrine · doi:10.1007/s12020-012-9609-z · Cited by 36
Turchi, F., Ronconi, V., di Tizio, V., Ceccoli, L., Boscaro, M., & Giacchetti, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.009 · Cited by 36
Myocardial and Aortic Stiffening in the Early Course of Primary Aldosteronism
Tsioufis, C. P., Tsiachris, D., Dimitriadis, K. S., Stougiannos, P. N., MISSOVOULOS, P., Kakkavas, A., Stefanadis, C., & Kallikazaros, I. E. (2008) · Clinical Cardiology · doi:10.1002/clc.20270 · Cited by 35
Sigurjónsdóttir, H. Á., Gronowitz, M., Andersson, O., Eggertsen, R., Herlitz, H., Sakinis, A., Wängberg, B., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-17 · Cited by 32
Hypertension Caused by Primary Hyperaldosteronism: Increased Heart Damage and Cardiovascular Risk
Abad-Cardiel, M., Álvarez-Álvarez, B., Luque-Fernandez, L., Fernández, C., Fernández‐Cruz, A., & Claros, N. M. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.07.017 · Cited by 23
Primary Aldosteronism: Clinical Lateralization and Costs
Funder, J. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3046 · Cited by 19
Shamliyan, T., Ansari, M., Raman, G., Berkman, N. D., Grant, M. D., Janes, G. R., Maglione, M., Moher, D., Nasser, M., Robinson, K. A., et al. (2013) · American journal of public health research · doi:10.12691/ajphr-1-7-7 · Cited by 15
Fardella, C., & Mosso, L. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.9994 · Cited by 9
Prevalence of primary aldosteronism among bulgarian hypertensive patients
Matrozova, J., Zacharieva, S., Кirilov, G., & Boyanov, M. (2010) · Open Medicine · doi:10.2478/s11536-010-0005-x · Cited by 6
Calhoun, D. A., Nishizaka, M., & Zaman, A. (2004) · Journal of Hypertension · doi:10.1097/00004872-200402001-00883 · Cited by 3
Cited by
Williams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 969
Self-citationPrevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Monticone, S., Burrello, J., Tizzani, D., Bertello, C., Viola, A., Buffolo, F., Gabetti, L., Mengozzi, G., Williams, T. A., Rabbia, F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.052 · Cited by 882
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf284 · Cited by 355
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Mulatero, P., Monticone, S., Deinum, J., Amar, L., Prejbisz, A., Zennaro, M.-C., Beuschlein, F., Rossi, G. P., Nishikawa, T., Morganti, A., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002510 · Cited by 317
Self-citation
Metadata
- Authors
- Käyser, S. C., Dekkers, T., Groenewoud, H. J., van der Wilt, G. J., Carel Bakx, J., van der Wel, M. C., Hermus, A. R., Lenders, J. W., & Deinum, J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-07
- Volume
- 101
- Issue
- 7
- Pages
- 2826-2835
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2387913746
- Cited by
- 398
- References
- 70
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.